Thomas Jonathan Stewart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas Jonathan Stewart has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- John Walter Frew
Department of Dermatology Liverpool Hospital Liverpool New South Wales Australia
11 shared publications Joshua Farrell
9 shared publications- Pablo Fernández-Peñas
Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia
4 shared publications - Gilberto Moreno Bonilla
The Skin Hospital Westmead New South Wales Australia
3 shared publications Hemali Shah
Medical University of South Carolina Charleston SC USA
3 shared publications- Joshua Farrell
Department of Dermatology Westmead Hospital Westmead New South Wales Australia
3 shared publications
Latest Publications
- 30 October 2026
- Published by Wiley in Australasian Journal of Dermatology
Prevalence of Hyperhidrosis: An Australian Population Study
Hyperhidrosis is a common but under‐recognised condition and this study aimed to determine its prevalence, clinical characteristics and healthcare utilisation among Australian adults. In a cross‐sectional, population‐based survey of 3000 Australian adults, 156 reported excessive or abnormal sweating, with 65% reporting severe disease, while younger age and student status were independently associated with hyperhidrosis. Despite the substantial burden of disease, only 49% had consulted a healthcare professional and 27% had received a formal diagnosis, highlighting a significant gap in recognition and healthcare engagement and the need for greater awareness and earlier diagnosis.
- 30 October 2026
- Published by Wiley in Australasian Journal of Dermatology
Prevalence of Hyperhidrosis: An Australian Population Study
Hyperhidrosis is a common but under‐recognised condition and this study aimed to determine its prevalence, clinical characteristics and healthcare utilisation among Australian adults. In a cross‐sectional, population‐based survey of 3000 Australian adults, 156 reported excessive or abnormal sweating, with 65% reporting severe disease, while younger age and student status were independently associated with hyperhidrosis. Despite the substantial burden of disease, only 49% had consulted a healthcare professional and 27% had received a formal diagnosis, highlighting a significant gap in recognition and healthcare engagement and the need for greater awareness and earlier diagnosis.
- 6 March 2026
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 67 (3)
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review of Cases Secondary to Topical Medications
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are typically triggered by systemic medications but can also result from topical agents. In this systematic review of SJS/TEN cases caused by topical agents, the drug culprits, disease characteristics, and outcomes were comparable to systemic cases. Our findings highlight that topical formulations, though generally considered safer, can induce SJS and TEN, underscoring the need for clinician awareness, early recognition and accurate reporting.
- 6 March 2026
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 67 (3)
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review of Cases Secondary to Topical Medications
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are typically triggered by systemic medications but can also result from topical agents. In this systematic review of SJS/TEN cases caused by topical agents, the drug culprits, disease characteristics, and outcomes were comparable to systemic cases. Our findings highlight that topical formulations, though generally considered safer, can induce SJS and TEN, underscoring the need for clinician awareness, early recognition and accurate reporting.
- 30 December 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 67 (2)
Factors to Predict 13 or More Sections in Mohs Micrographic Surgery
Background/Objectives: Studies on factors that predict the number of stages in Mohs micrographic surgery (MMS) have been published previously. To date, no studies have analysed the predictors for the number of sections during MMS. Methods: A retrospective case–control study of patients treated for keratinocyte cancer (KC) between 2013 and 2017 was conducted to identify predictive factors for 13 or more MMS sections. Patient, tumour, management and practitioner‐related factors were analysed with univariate logistic regression and a multivariate predictive model. Surface area for tumours and defects was studied in cases and controls as a secondary outcome. Results: Out of 10,132 tumours, a total of 195 cases representing 1.9% of all MMS procedures for the study period required more than 13 MMS sections. A control group with 213 tumours was also randomly selected. Largest preoperative tumour diameter, mixed histology, tumour recurrence and age were significant predictors for 13 or more MMS sections in a multivariate model (AUC 88.4%, sensitivity 77.2% and specificity 87.0%). Significantly larger defects were also found in our cases compared to the control group (median tumour to defect ratio 3.94 vs. 2.43; p < 0.0001). Conclusion: Identifying factors that predict 13 or more sections prior to surgery could assist the Mohs practitioner in informing patients and allocating time and resources accordingly.
- 30 December 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 67 (2)
Factors to Predict 13 or More Sections in Mohs Micrographic Surgery
Background/Objectives: Studies on factors that predict the number of stages in Mohs micrographic surgery (MMS) have been published previously. To date, no studies have analysed the predictors for the number of sections during MMS. Methods: A retrospective case–control study of patients treated for keratinocyte cancer (KC) between 2013 and 2017 was conducted to identify predictive factors for 13 or more MMS sections. Patient, tumour, management and practitioner‐related factors were analysed with univariate logistic regression and a multivariate predictive model. Surface area for tumours and defects was studied in cases and controls as a secondary outcome. Results: Out of 10,132 tumours, a total of 195 cases representing 1.9% of all MMS procedures for the study period required more than 13 MMS sections. A control group with 213 tumours was also randomly selected. Largest preoperative tumour diameter, mixed histology, tumour recurrence and age were significant predictors for 13 or more MMS sections in a multivariate model (AUC 88.4%, sensitivity 77.2% and specificity 87.0%). Significantly larger defects were also found in our cases compared to the control group (median tumour to defect ratio 3.94 vs. 2.43; p < 0.0001). Conclusion: Identifying factors that predict 13 or more sections prior to surgery could assist the Mohs practitioner in informing patients and allocating time and resources accordingly.
- 22 November 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 67 (1) , 18-23
Ten Years of Scalp Keratinocyte Carcinomas (Basal Cell Carcinomas and Squamous Cell Carcinomas) Treated by Mohs Micrographic Surgery at a Large Australian Centre, a Descriptive Study
Background: There is a paucity of data on scalp keratinocyte carcinomas (KCs) referred for Mohs micrographic surgery (MMS). This study aimed to perform a descriptive analysis of scalp KCs—specifically basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs)—treated with MMS at The Skin Hospital in Sydney, Australia. Methods: We performed a retrospective analysis of all scalp KCs treated with MMS from October 2012 to September 2022 from an electronic database. Extracted data included age, sex, tumour histology and aggressiveness, anatomical location, preoperative tumour size, final defect size, number of MMS stages and sections, extensive subclinical spread and repair method. Results: We identified 1177 scalp KCs treated with MMS in 889 patients, consisting of 948 BCCs (80.5%) and 229 SCCs (19.5%). The median age of patients with BCCs was significantly younger (60 years) than that of SCCs (73 years) ( p < 0.001). SCCs were more commonly found in males (182/229, 79%) ( p < 0.001). The majority of KCs were located on the frontal scalp (948/1177, 55%). BCCs were more likely to be of an aggressive subtype (58%, 512/876) than SCCs (21%, 44/212) ( p < 0.001). The median largest tumour and defect diameter was larger for SCCs than for BCCs ( p < 0.001). There was no significant difference in the median number of MMS stages for tumour type ( p = 0.121). Extensive subclinical spread was more common for aggressive SCCs (13/44, 29.5%) than for BCCs (84/511, 16.4%) ( p = 0.028). Primary closure repair was most common (55%, 644/1177). Conclusion: The observed differences in patient, tumour and treatment characteristics may help inform clinical practice and inspire further research.
- 22 November 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 67 (1) , 18-23
Ten Years of Scalp Keratinocyte Carcinomas (Basal Cell Carcinomas and Squamous Cell Carcinomas) Treated by Mohs Micrographic Surgery at a Large Australian Centre, a Descriptive Study
Background: There is a paucity of data on scalp keratinocyte carcinomas (KCs) referred for Mohs micrographic surgery (MMS). This study aimed to perform a descriptive analysis of scalp KCs—specifically basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs)—treated with MMS at The Skin Hospital in Sydney, Australia. Methods: We performed a retrospective analysis of all scalp KCs treated with MMS from October 2012 to September 2022 from an electronic database. Extracted data included age, sex, tumour histology and aggressiveness, anatomical location, preoperative tumour size, final defect size, number of MMS stages and sections, extensive subclinical spread and repair method. Results: We identified 1177 scalp KCs treated with MMS in 889 patients, consisting of 948 BCCs (80.5%) and 229 SCCs (19.5%). The median age of patients with BCCs was significantly younger (60 years) than that of SCCs (73 years) ( p < 0.001). SCCs were more commonly found in males (182/229, 79%) ( p < 0.001). The majority of KCs were located on the frontal scalp (948/1177, 55%). BCCs were more likely to be of an aggressive subtype (58%, 512/876) than SCCs (21%, 44/212) ( p < 0.001). The median largest tumour and defect diameter was larger for SCCs than for BCCs ( p < 0.001). There was no significant difference in the median number of MMS stages for tumour type ( p = 0.121). Extensive subclinical spread was more common for aggressive SCCs (13/44, 29.5%) than for BCCs (84/511, 16.4%) ( p = 0.028). Primary closure repair was most common (55%, 644/1177). Conclusion: The observed differences in patient, tumour and treatment characteristics may help inform clinical practice and inspire further research.
- 31 October 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 66 (8)
Psychological Complications of Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta‐Analysis
Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, severe mucocutaneous diseases associated with high rates of mortality. While the acute complications of SJS and TEN are well documented, it is being increasingly recognised that survivors may develop psychological sequelae that can be associated with significant morbidity. This systematic review and meta‐analysis aimed to critically evaluate observational studies of psychiatric complications and quality of life in adults with SJS and TEN. This review was registered with INPLASY and conducted in accordance with the PRISMA reporting guidelines. Potential bias was assessed using the NIH criteria. Ten articles describing results from 1123 cases and 2687 controls were included. The overall quality of the studies was suboptimal, and the level of heterogeneity was very high ( I 2 = 96%). Meta‐analysis of eight studies with fifteen study groups ( n = 2120) showed a prevalence of psychiatric complications of 24.9% in SJS and TEN patients. SJS and TEN survivors appear to suffer a high burden of psychological complications, including post‐traumatic stress disorder, depression, anxiety, as well as quality of life impairment. This population would likely benefit from early multidisciplinary input and long‐term follow‐up; however, additional larger controlled studies are needed.
- 31 October 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 66 (8)
Psychological Complications of Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta‐Analysis
Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, severe mucocutaneous diseases associated with high rates of mortality. While the acute complications of SJS and TEN are well documented, it is being increasingly recognised that survivors may develop psychological sequelae that can be associated with significant morbidity. This systematic review and meta‐analysis aimed to critically evaluate observational studies of psychiatric complications and quality of life in adults with SJS and TEN. This review was registered with INPLASY and conducted in accordance with the PRISMA reporting guidelines. Potential bias was assessed using the NIH criteria. Ten articles describing results from 1123 cases and 2687 controls were included. The overall quality of the studies was suboptimal, and the level of heterogeneity was very high ( I 2 = 96%). Meta‐analysis of eight studies with fifteen study groups ( n = 2120) showed a prevalence of psychiatric complications of 24.9% in SJS and TEN patients. SJS and TEN survivors appear to suffer a high burden of psychological complications, including post‐traumatic stress disorder, depression, anxiety, as well as quality of life impairment. This population would likely benefit from early multidisciplinary input and long‐term follow‐up; however, additional larger controlled studies are needed.
- 12 July 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Stevens Johnson syndrome and toxic epidermal necrolysis due to topical drugs: A systematic review of case reports
INPLASY202570052 Stevens Johnson syndrome and toxic epidermal necrolysis due to topical drugs: A systematic review of case reports Keywords: Stevens Johnson syndrome and toxic epidermal necrolysis …
- 12 July 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Stevens Johnson syndrome and toxic epidermal necrolysis due to topical drugs: A systematic review of case reports
INPLASY202570052 Stevens Johnson syndrome and toxic epidermal necrolysis due to topical drugs: A systematic review of case reports Keywords: Stevens Johnson syndrome and toxic epidermal necrolysis …
- 11 June 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
The effects of isotretinoin on serum thyroid parameters: A systematic review and meta-analysis
INPLASY202560049 The effects of isotretinoin on serum thyroid parameters: A systematic review and meta-analysis Keywords: Isotretinoin, thyroid hormones, thyroid-stimulating hormone, thyroxine, tri…
- 11 June 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
The effects of isotretinoin on serum thyroid parameters: A systematic review and meta-analysis
INPLASY202560049 The effects of isotretinoin on serum thyroid parameters: A systematic review and meta-analysis Keywords: Isotretinoin, thyroid hormones, thyroid-stimulating hormone, thyroxine, tri…
- Open Access
- 17 April 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (4) , e70106
Factors Associated With Completion of Isotretinoin Therapy in Acne Patients Reporting Mood Disturbance
- 17 April 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (4) , e70106
Open AccessFactors Associated With Completion of Isotretinoin Therapy in Acne Patients Reporting Mood Disturbance
- 3 April 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 66 (4)
The Surgical and Aesthetic Complications of Mohs Micrographic Surgery in an Australian Cohort
Australian research on the complications of Mohs micrographic surgery (MMS) is scarce. We reviewed our MMS cases for patient, tumour, and treatment factors, as well as surgical complications and aesthetic dissatisfaction. Our results reaffirm international data showing that MMS in Australia has low complication rates (≤ 2%). Smoking, anticoagulant use, tumour anatomic site, defect size, and repair method may affect the risk of surgical complications, and patient age and sex may influence the risk of aesthetic dissatisfaction.
- 3 April 2025
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 66 (4)
The Surgical and Aesthetic Complications of Mohs Micrographic Surgery in an Australian Cohort
Australian research on the complications of Mohs micrographic surgery (MMS) is scarce. We reviewed our MMS cases for patient, tumour, and treatment factors, as well as surgical complications and aesthetic dissatisfaction. Our results reaffirm international data showing that MMS in Australia has low complication rates (≤ 2%). Smoking, anticoagulant use, tumour anatomic site, defect size, and repair method may affect the risk of surgical complications, and patient age and sex may influence the risk of aesthetic dissatisfaction.